04/05/2016 19:07:03 1-888-992-3836 (toll free) Free Membership Login

Edwards Lifesciences News (NYSE:EW)

DateTimeSource
Headline
05/02/20161:48PMPRNUSEdwards Lifesciences To Present At The Deutsche Bank 41st Annual Health Care Conference
Edwards Lifesciences To Present At The Deutsche Bank 41st Annual Health Care Conference PR Newswire IRVINE, Calif., May 2, 2016 IRVINE, Calif., May 2, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring... More...>>
04/26/20165:00PMDJNEdwards Lifesciences Raises 2016 View
Edwards Lifesciences Corp. again raised its 2016 guidance as strong sales of the medical device maker's nonsurgical heart valves drove better-than-expected profit and revenue for the first quarter. The devices, known as transcatheter heart valves, provide an alternative option for elderly patients who are considered... More...>>
04/26/20164:15PMPRNUSEdwards Lifesciences Reports First Quarter Results
Edwards Lifesciences Reports First Quarter Results PR Newswire IRVINE, Calif., April 26, 2016 IRVINE, Calif., April 26, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial... More...>>
04/12/201610:10AMPRNUSEdwards Lifesciences To Host Earnings Conference Call On April 26, 2016
Edwards Lifesciences To Host Earnings Conference Call On April 26, 2016 PR Newswire IRVINE, Calif., April 12, 2016 IRVINE, Calif., April 12, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans... More...>>
04/04/201612:50PMDJNEdwards Lifesciences Shares Soar on Heart-Valve Procedure Study Results
Edwards Lifesciences Corp. shares hit an all-time high Monday after the company issued data this weekend showing its less-invasive heart-valve procedure wasn't inferior to open-heart surgery and was superior in some cases. Dr. Vinod Thourani, co-principal investigator of the study, said results should establish the... More...>>
04/03/201611:45AMPRNUSEdwards SAPIEN 3 TAVR Demonstrates Clinical Superiority To Surgery In PARTNER II Study
Edwards SAPIEN 3 TAVR Demonstrates Clinical Superiority To Surgery In PARTNER II Study Trial Studied Severe, Symptomatic Aortic Stenosis Patients at Intermediate Risk for Surgery PR Newswire CHICAGO, April 3, 2016 CHICAGO, April 3, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in... More...>>
04/02/20169:00AMPRNUSEdwards SAPIEN XT Valve Meets Primary Endpoint In PARTNER II Trial
Edwards SAPIEN XT Valve Meets Primary Endpoint In PARTNER II Trial PR Newswire CHICAGO, April 2, 2016 CHICAGO, April 2, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the randomized... More...>>
03/17/20164:15PMPRNUSSteven Loranger Appointed To Edwards Lifesciences Board Of Directors
Steven Loranger Appointed To Edwards Lifesciences Board Of Directors PR Newswire IRVINE, Calif., March 17, 2016 IRVINE, Calif., March 17, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced... More...>>
03/16/20169:15AMPRNUSEdwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan
Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan PR Newswire IRVINE, Calif., March 16, 2016 IRVINE, Calif., March 16, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced... More...>>
03/02/20169:15AMPRNUSEdwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures
Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures PR Newswire IRVINE, Calif., March 2, 2016 IRVINE, Calif., March 2, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced... More...>>
02/04/20166:34PMPRNUSEdwards Lifesciences Announces $325 Million Accelerated Share Repurchase
Edwards Lifesciences Announces $325 Million Accelerated Share Repurchase PR Newswire IRVINE, Calif., Feb. 4, 2016 IRVINE, Calif., Feb. 4, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced... More...>>
02/03/201610:05AMPRNUSEdwards Lifesciences To Present At The Leerink Global Healthcare Conference
Edwards Lifesciences To Present At The Leerink Global Healthcare Conference PR Newswire IRVINE, Calif., Feb. 3, 2016 IRVINE, Calif., Feb. 3, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled... More...>>
02/02/20164:50PMDJNEdwards Lifesciences Revenue Rises 8.6%, 2016 Outlook Raised
Edwards Lifesciences Corp. said its fourth-quarter revenue rose 8.6% on continued strong sales growth for the medical-device maker's nonsurgical heart valves. The medical-device maker also raised its 2016 outlook and projected fourth-quarter results mostly above analysts' views. The Irvine, Calif., company reported... More...>>
02/02/20164:15PMPRNUSEdwards Lifesciences Reports Fourth Quarter Results
Edwards Lifesciences Reports Fourth Quarter Results PR Newswire IRVINE, Calif., Feb. 2, 2016 IRVINE, Calif., Feb. 2, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results... More...>>
01/21/20169:45AMPRNUSEdwards Lifesciences To Host Earnings Conference Call On February 2, 2016
Edwards Lifesciences To Host Earnings Conference Call On February 2, 2016 PR Newswire IRVINE, Calif., Jan. 21, 2016 IRVINE, Calif., Jan. 21, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, plans to announce its operating results... More...>>
01/15/20168:30AMPRNUSEdwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve
Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve PR Newswire IRVINE, Calif., Jan. 15, 2016 IRVINE, Calif., Jan. 15, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today... More...>>
01/06/201610:10AMPRNUSEdwards Lifesciences To Present At The 34th Annual J.P. Morgan Healthcare Conference
Edwards Lifesciences To Present At The 34th Annual J.P. Morgan Healthcare Conference PR Newswire IRVINE, Calif., Jan. 6, 2016 IRVINE, Calif., Jan. 6, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring... More...>>
12/09/20159:15AMPRNUSEdwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference PR Newswire IRVINE, Calif., Dec. 9, 2015 IRVINE, Calif., Dec. 9, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, will discuss the company's strategy... More...>>
11/19/20154:30PMPRNUSEdwards Lifesciences Announces Two-for-One Stock Split
Edwards Lifesciences Announces Two-for-One Stock Split PR Newswire IRVINE, Calif., Nov. 19, 2015 IRVINE, Calif., Nov. 19, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced today that its board of directors approved a... More...>>
10/26/20155:50PMDJNEdwards Lifesciences Revenue Rises 1.3%
Edwards Lifesciences Corp. said its third-quarter revenue rose 1.3% as continued strong sales growth for the medical-device maker's nonsurgical heart values was muted by impacts from a strong U.S. dollar. The Irvine, Calif., company's revenue increased to $615.5 million from $607.4 million a year earlier. Edwards... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V:us D:20160504 23:07:05